China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2026...
Qiming Venture Partners Managing Partner Alex Zhou Named to 2026 Forbes Midas List
SHANGHAI, May 29, 2026 /PRNewswire/ -- Forbes has released its 2026 Midas List, the definitive ranking of the world's top venture capital investors. Alex Zhou, Managing Partner at Qiming Venture Partners, debuts at No. 80, recognizing his track...
Domestic Display Chip Leader Viewtrix Technology Listed on Hong Kong Stock Exchange
SHANGHAI, May 27, 2026 /PRNewswire/ -- Viewtrix Technology, a portfolio company of Qiming Venture Partners and a leading display chip design enterprise in China, successfully listed on the Hong Kong Stock Exchange, marking the sixth IPO for Qiming...
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar...
Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round
NEW YORK, April 20, 2026 /PRNewswire/ -- Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic financing...
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies SUZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Vivatides Therapeutics, a global biotechnology company focused on developing extrahepatic...
Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange
SHANGHAI, Feb. 11, 2026 /PRNewswire/ -- Axera, a portfolio company of Qiming Venture Partners and a leading Chinese edge AI chip company, successfully listed on the Hong Kong Stock Exchange on February 10th, 2026, Beijing time, becoming the first of...
Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange's STAR Market on February 5,...
China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange
SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Z.ai (formerly known as Zhipu AI), a pioneer and leader inartificial general intelligence (AGI) in China, successfully listed on the Hong Kong Stock Exchange on...
Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange
SHANGHAI, Jan. 2, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Biren Technology, a leading domestic GPU developer, successfully listed on the Hong Kong Stock Exchange today, becoming the first company to go public in Hong Kong in...